Skip to main content
Neogen Chemicals Limited logo

Neogen Chemicals Limited — Investor Relations & Filings

Ticker · NEOGEN ISIN · INE136S01016 LEI · 335800PFY9B77Z2GOK22 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2025-01-27 Regulatory Filings
Country IN India
Listing BSE.NS NEOGEN

About Neogen Chemicals Limited

https://neogenchem.com/

Neogen Chemicals Limited specializes in the development and large-scale manufacturing of bromine-based and lithium-based specialty chemicals. The product portfolio includes a diverse range of bromine derivatives, lithium salts, Grignard reagents, and advanced intermediates. These products serve critical roles in pharmaceutical, agrochemical, and engineering applications. The company has expanded its operations into the energy storage market, focusing on the production of electrolytes and lithium salts for lithium-ion batteries. With a strong emphasis on research and development, the firm provides custom synthesis and contract manufacturing services to global innovators. Manufacturing capabilities are supported by multi-product facilities designed to meet stringent quality standards for complex chemical processes and high-purity requirements.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice of an upcoming Board Meeting scheduled for February 1, 2025, to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2024. It is an intimation pursuant to SEBI Listing Regulations, specifically regulation 29, which governs disclosures related to board meetings. The document does not contain any financial data or results itself, nor does it include a full report or detailed financial analysis. It is a formal announcement of a board meeting and related compliance information. Given the document length (2079 characters) and content, it is not a full Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a regulatory announcement about the board meeting. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2025-01-27 English
Amalgamation/Merger
M&A Activity Classification · 100% confidence The document is a detailed official communication from Neogen Chemicals Limited to stock exchanges regarding the sanctioning of a Scheme of Amalgamation by the National Company Law Tribunal (NCLT). It includes the full text of the NCLT order approving the merger of a wholly owned subsidiary into the parent company, with extensive legal and procedural details, references to the Companies Act, and compliance with regulatory requirements. The content is focused on a merger/amalgamation transaction, including legal approvals and procedural steps, rather than a financial report, earnings release, or general regulatory announcement. This fits the definition of a M&A Activity filing, which covers announcements and documents related to merger proposals or takeover bids. The document is substantive and not merely an announcement of a report, so it is not an RPA or RNS. Therefore, the correct classification is TAR (M&A Activity).
2025-01-09 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal announcement dated January 9, 2025, from Neogen Chemicals Limited to stock exchanges regarding the pronouncement of an order by the National Company Law Tribunal (NCLT) sanctioning a Scheme of Amalgamation between Neogen Chemicals Limited and its wholly owned subsidiary Buli Chemicals India Private Limited. The text includes references to the Companies Act, 2013, the NCLT order, and detailed explanations of the scheme, benefits, and compliance with regulatory requirements. The document is not a financial report but a regulatory announcement about a corporate restructuring event (amalgamation). It is not a merger proxy statement or tender offer filing but an official regulatory announcement under SEBI Listing Regulations about the sanctioning of a scheme by a tribunal. This fits best under the category of Regulatory Filings (RNS), as it is a regulatory announcement that does not fit into more specific categories like M&A filings (which are typically merger proxy statements or tender offers) or Capital/Financing Updates. The document is lengthy (15,000 characters) and contains substantive legal and regulatory information but is not a financial report or earnings release. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-01-09 English
Amalgamation/Merger
Regulatory Filings Classification · 95% confidence The document is a formal announcement dated January 9, 2025, from Neogen Chemicals Limited regarding the pronouncement of an order by the National Company Law Tribunal (NCLT) sanctioning a Scheme of Amalgamation between Neogen Chemicals Limited and its wholly owned subsidiary Buli Chemicals India Private Limited. The text includes references to the Companies Act, 2013, the Scheme of Amalgamation, and the procedural compliance with regulatory authorities. It contains detailed legal and procedural information about the merger, including benefits, compliance undertakings, and reports from various authorities. The document is not a financial report, earnings release, or management discussion but a regulatory announcement about a corporate restructuring event. It is an official regulatory filing under SEBI Listing Regulations, specifically a disclosure under Regulation 30 about a significant corporate event (amalgamation approval). This fits best under Regulatory Filings (RNS) as it is a formal regulatory announcement and not a merger proxy statement or tender offer filing (which would be MA or TAR). The document is lengthy and detailed but does not contain financial statements or earnings data, so it is not an Annual Report or Interim Report. It is not a report publication announcement since it is the actual announcement of the order sanctioning the scheme. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-01-09 English
Updates
Regulatory Filings Classification · 100% confidence The document is a formal notification addressed to stock exchanges about a change in the name of the company's Registrar and Share Transfer Agent (RTA). It includes a certificate of incorporation issued by the Ministry of Corporate Affairs confirming the name change. The content is regulatory in nature, informing stakeholders and regulators about the change, without any financial data, analysis, or report. The document length is short (3636 characters) and it serves as an announcement rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal communication from Neogen Chemicals Limited to stock exchanges regarding the closure of the trading window in compliance with insider trading regulations. It announces the trading window closure period around the upcoming declaration of un-audited quarterly and nine-month financial results. There is no actual financial data, report, or detailed analysis included. The document is short (2244 characters) and serves as an announcement related to the timing of financial results and trading restrictions, not the results themselves. Therefore, it fits best as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Earnings Release (ER).
2024-12-27 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.